The real estate investment trust, which primarily invests in real estate serving the healthcare industry in the U.S., is expected to report earnings of 77 cents per share and revenue of $534.61 million, down from 79 cents per share and $543.96 million a year ago, according to the average of analyst estimates compiled by Yahoo Finance.
Additionally, HCP announced today that it will provide approximately $630 million in financing for Formation Capital LLC and Safanad Limited's pending acquisition of NHP Ltd, a company that owns 273 nursing and residential care homes in the UK.
Separately, TheStreet Ratings team rates HCP INC as a Buy with a ratings score of A-. TheStreet Ratings Team has this to say about their recommendation:
"We rate HCP INC (HCP) a BUY. This is based on the convergence of positive investment measures, which should help this stock outperform the majority of stocks that we rate. The company's strengths can be seen in multiple areas, such as its revenue growth, growth in earnings per share, expanding profit margins, good cash flow from operations and increase in stock price during the past year. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results."
You can view the full analysis from the report here: HCP Ratings Report